OABI Q1 2023 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M+75.8% YoY

Gross Profit

$13M74.2% margin

Operating Income

-$8M-49.7% margin

Net Income

-$6M-36.1% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

-52.1%

Cash Flow

Operating Cash Flow

$28M

Free Cash Flow

$27M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$413M

Total Liabilities

$72M

Stockholders' Equity

$341M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$10M	+75.8%
Gross Profit	$13M	$6M	+123.4%
Operating Income	-$8M	-$9M	+3.0%
Net Income	-$6M	-$6M	+2.9%

Revenue Segments

Service

$4M93%

Royalty

$315,0007%